TNFRSF10B and hepatocellular carcinoma: Our studies show that oral administration of WA effectively inhibits HepG2-xenografts in athymic nude mice and DEN-induced HCC in C57BL/6 mice and present a novel mechanism of WA action through activation of ERK-ELK1-DR5 axis.